Enzolytics, Inc. ENZC
Set alert
0.00 USD 0.00 0.00%
As of Nov 2, 3:31 PM ET
0.0004 Day range 0.0004
0.0002 52-week range 0.0013
- YTD
- +33.33%
- 1 year
- +33.33%
- Open
- 0.0004
- Prev close
- 0.0004
- Mkt cap
- 1.93M
- Vol
- 491.94K
- Avg vol
- 3.58M
- EPS
- -0.34
- P/E
- 0.00
More statistics
- Low
- 0.0004
- High
- 0.0004
5Y chart
Signals (75)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| SMA: Bearish | Aug 3, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 20, 2026 | 3 months ago |
| SMA: Bearish | Jul 6, 2026 | 3 months ago |
| MACD: Buy Signal | Apr 27, 2026 | 6 months ago |
| SMA: Bullish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 20, 2026 | 6 months ago |
| SMA: Bearish | Apr 13, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 13, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 6, 2026 | 7 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 23, 2026 | 7 months ago |
| SMA: Bearish | Mar 9, 2026 | 7 months ago |
| SMA: Bullish | Jan 12, 2026 | 9 months ago |
| SMA: Bullish | Dec 22, 2025 | 10 months ago |
| SMA: Bearish | Nov 10, 2025 | 11 months ago |
| SMA: Bullish | Nov 3, 2025 | 12 months ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| SMA: Bullish | Oct 20, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 20, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 29, 2025 | 1 year ago |
| SMA: Bearish | Aug 18, 2025 | 1 year ago |
| SMA: Bullish | Aug 11, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| SMA: Bullish | Jul 21, 2025 | 1 year ago |
| SMA: Bullish | Jul 14, 2025 | 1 year ago |
| SMA: Bullish | Apr 28, 2025 | 1 year ago |
| SMA: Bearish | Jan 13, 2025 | 1 year ago |
| SMA: Bullish | Jan 6, 2025 | 1 year ago |
| RSI: Oversold | Nov 11, 2024 | 1 year ago |
| SMA: Bearish | Sep 2, 2024 | 2 years ago |
| SMA: Bullish | Jul 29, 2024 | 2 years ago |
| MACD: Buy Signal | May 20, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 15, 2024 | 2 years ago |
| RSI: Oversold | Apr 15, 2024 | 2 years ago |
| SMA: Bearish | Mar 4, 2024 | 2 years ago |
| SMA: Bullish | Feb 26, 2024 | 2 years ago |
| MACD: Buy Signal | Jan 29, 2024 | 2 years ago |
| SMA: Bearish | Jan 15, 2024 | 2 years ago |
| SMA: Bullish | Jan 8, 2024 | 2 years ago |
| RSI: Oversold | Dec 18, 2023 | 2 years ago |
| SMA: Bearish | Sep 25, 2023 | 3 years ago |
| SMA: Bullish | Sep 18, 2023 | 3 years ago |
| SMA: Bearish | Sep 4, 2023 | 3 years ago |
| SMA: Bullish | Aug 28, 2023 | 3 years ago |
| SMA: Bearish | Jun 19, 2023 | 3 years ago |
| SMA: Bullish | Jun 12, 2023 | 3 years ago |
| MACD: Sell Signal | Jun 5, 2023 | 3 years ago |
| SMA: Bearish | May 22, 2023 | 3 years ago |
| SMA: Bearish | May 15, 2023 | 3 years ago |
| RSI: Overbought | May 1, 2023 | 3 years ago |
| SMA: Bullish | Apr 17, 2023 | 3 years ago |
| SMA: Bearish | Apr 10, 2023 | 3 years ago |
| SMA: Bullish | Apr 3, 2023 | 3 years ago |
| SMA: Bearish | Mar 13, 2023 | 3 years ago |
| SMA: Bullish | Feb 6, 2023 | 3 years ago |
| SMA: Bullish | Jan 16, 2023 | 3 years ago |
| SMA: Bearish | Dec 26, 2022 | 3 years ago |
| SMA: Bullish | Dec 19, 2022 | 3 years ago |
| SMA: Bearish | Nov 28, 2022 | 3 years ago |
| MACD: Buy Signal | Oct 17, 2022 | 4 years ago |
| SMA: Bullish | Oct 10, 2022 | 4 years ago |
| RSI: Oversold | Sep 26, 2022 | 4 years ago |
| MACD: Sell Signal | Aug 22, 2022 | 4 years ago |
| SMA: Bearish | Jul 11, 2022 | 4 years ago |
| SMA: Bullish | Jul 4, 2022 | 4 years ago |
| SMA: Bearish | Jun 13, 2022 | 4 years ago |
| SMA: Bullish | Jun 6, 2022 | 4 years ago |
| SMA: Bearish | May 9, 2022 | 4 years ago |
| SMA: Bullish | Apr 25, 2022 | 4 years ago |
| SMA: Bearish | Feb 14, 2022 | 4 years ago |
| SMA: Bullish | Feb 7, 2022 | 4 years ago |
| SMA: Bearish | Jan 17, 2022 | 4 years ago |
News
- Bulgarian Academy of Sciences Issues Report on Results of Its In Vivo Testing of IPF as an Immunomodulator
- Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences and Enzolytics, Inc. Execute Three Year Agreement
- Final Report From the National Centre of Infectious and Parasitic Diseases Concludes Lyophilized Pepsin Significantly Reduces the Survival and Proliferation of Growth in Specific Cancer Cells
- Enzolytics, Inc. and the Bulgarian Academy of Sciences Initiate a Cooperative Program Primarily Focusing on Applied and Strategic Research in Immunology for Cancer and HIV/AIDS Applications
- Enzolytics, Inc. Enters Into Collaboration Agreement With Manufacturer Elimus Ltd.
- Enzolytics Inc. Supports Sagaliam Acquisition Corp Response to Competitors False and Misleading Press Release
- Enzolytics, Inc. Enters Into Exclusive Worldwide License for Patented Immunotherapy Cancer Treatment
- Enzolytics, Inc. Poised to Invest Alongside Sagaliam Acquisition Corp in Revolutionary Room Temperature SPAD Technology
- Enzolytics, Inc. Announces Formation of Marketing Company in Partnership with Third Coast Fulfillment
- Sagaliam Acquisition Corp. Announces Novation Agreement with Enzolytics, Inc.
Your note
Sign in to keep a note on ENZC — it syncs with the Stock Master app.